Skip to main content
Clinical Trials/IRCT20190505043485N1
IRCT20190505043485N1CompletedPhase 3

Determination of the Effect of Oral zinc therapy on the Treatment of Acne vulgaris in Patients with Grade 2 and 3 Acne vulgaris

Boushehr University of Medical Sciences0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 40 years (—)
Sex
All

Inclusion Criteria

  • 2nd and 3rd grade of Acne Vulgaris patients depends on Pillsburg classification

Exclusion Criteria

  • The patients with Gastrointestinal disorder
  • The pregnant patients and breast feeding mothers
  • Using other topical and oral anti Acne drugs
  • Patients with Grade 1 and 4 Acne Vulgaris
  • Female patients with hormonal disorders
  • Patients with oral Isotretinoin in the last 3 months

Investigators

Sponsor
Boushehr University of Medical Sciences

Similar Trials